Relationship between hypothyroidism and hyperprolactinemia
- Авторлар: Shormanova L.Z.1, Gabdiliashimova Z.T.1, Khamidullina Z.G.1, Akhmediyanova G.U.1
-
Мекемелер:
- Astana Medical University
- Шығарылым: № 12 (2022)
- Беттер: 46-49
- Бөлім: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/250283
- DOI: https://doi.org/10.18565/aig.2022.209
- ID: 250283
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
Авторлар туралы
Lyailya Shormanova
Astana Medical University
Email: lyailyazhansultanovna@gmail.com
Doctoral Candidate, PhD, First-Year
Zarema Gabdiliashimova
Astana Medical UniversityMD, Associate Professor, Obstetrics and Gynecology Department One
Zaituna Khamidullina
Astana Medical UniversityCand. Med. Sci., PhD, Head, Obstetrics and Gynecology Department One
Gainyl Akhmediyanova
Astana Medical UniversityCand. Med. Sci., Professor, Obstetrics and Gynecology Department One
Әдебиет тізімі
- Chiovato L., Magri F., Carle A. Hypothyroidism in eontext: where we've been and where we're going. Adv. Ther. 2019; 36(Suppl. 2): 47-58.
- Garmendia Madariaga A., Santos Palacios S., Guillen-Grima F., Galofre J.C. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J. Clin. Endocrinol. Metab 2014; 99(3): 923-31. https://dx.doi.org/10.1210/jc.2013-2409.
- Гарднер Д., Шобек Д. Базисная и клиническая эндокринология. М.: БИНОМ; 2011. 304c.
- Chaker L., Bianco A.C., Jonklaas J., Peeters R.P. Hypothyroidism. Lancet. 2017; 390(10101): 1550-62. https://dx.oi.org/10.1016/S0140-6736(17)30703-1.
- Capozzi A., Scambia G., Pontecorvi A., Lello S. Hyperprolactinemia: pathophysiology and therapeutic approach. Gynecol. Endocrinol. 2015; 31(7): 506-10. https://dx.doi.org/10.3109/09513590.2015.1017810.
- Samperi I., Lithgow K., Karavitaki N. Hyperprolactinaemia. J. Clin. Med. 2019; 8(12): 2203. https://dx.doi.org/10.3390/jcm8122203.
- Kars M., Souverein P.C., Herings R.M., Romijn J.A., Vandenbroucke J.P., de Boer A., Dekkers O.M. Estimated ageand sex-specific incidence and prevalence of dopamine agonist-treated hyperprolactinemia. J. Clin. Endocrinol. Metab. 2009; 94(8): 2729-34. https://dx.doi.org/10.1210/jc.2009-0177.
- Jacobs L.S., Snyder PJ., Wilber J.F. Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (trh) in man. J. Clin. Endocrinol. Metab. 1971; 33(6): 996-8. https://dx.doi.org/10.1210/jcem-33-6-996.
- Bowers C.Y., Friesen H.G., Hwang P., Guyda H.J., Folkers К. Prolactin and thyrotropin release in man by synthetic pyroglutamyl-histidyl-prolinamide. Biochem. Biophys. Res. Commun. 1971; 45(4): 1033-41. https://dx.doi.org/10.1016/0006-291x(71)90441-4.
- Fox T.J., Anastasopoulou C. Pituitary hyperplasia in primary hypothyroidism. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan.
- Katznelson L., Riskind P.N., Saxe V.C., Klibanski A. Prolactin pulsatile characteristics in postmenopausal women. J. Clin. Endocrinol. Metab. 1998; 83(3): 761-4. https://dx.doi.org/10.1210/jcem.83.3.4675.
- Олейник В.А., Эпштейн Е.В., Савран Е.В. Гиперпролактинемия и гипотиреоз (синдром Ван Вика-Росса-Геннеса). Проблемы эндокринологии. 1996; 42(1): 40-3.
- Honbo K.S., Van Herle A.J., Kellett K.A. Serum prolactin levels in untreated primary hypothyroidism. Am. J. Med. 1978; 64(5): 782-7. https://dx.doi.org/10.1016/0002-9343(78)90517-x.
- Notsu K., Ito Y., Furuya H., Ohguni S., Katoet Y. Incidence of hyperprolactinemia in patients with hashimoto's thyroiditis. Endocr. J. 1997; 44(1): 89-94. https://dx.doi.org/10.1507/endocrj.44.89.
- Sharma L.K., Sharma N., Gadpayle A.K., Dutta D. Prevalence and predictors of hyperprolactinemia in subclinical hypothyroidism. Eur. J. Intern. Med. 2016; 35: 106-10. https://dx.doi.org/10.1016/j.ejim.2016.07.012.
- Meier C., Christ-Crain M., Guglielmetti M., Huber P., Staub J., Mulleret B. Prolactin dysregulation in women with subclinical hypothyroidism: effect of levothyroxine replacement therapy. Thyroid. 2003; 13(10): 979-85. https://dx.doi.org/10.1089/105072503322511391.
- Goel P., Kahkasha., Narang S., Gupta B.K., Goel K. Evaluation of serum prolactin level in patients of subclinical and overt hypothyroidism. J. Clin. Diagn. Res. 2015; 9(1): BC15-7. https://dx.doi.org/10.7860/JCDR/2015/9982.5443.
- Khorassanizadeh R., Sundaresh V., Levine S.N. Primary hypothyroidism with exceptionally high prolactin-A really big deal. World Neurosurg. 2016; 91: 675. e11-4. https://dx.doi.org/10.1016/j.wneu.2016.04.103.
- Гнадь Ю.Г. Сочетание гиперпролактинемии и субклинического гипотиреоза. Медицинский совет. 2009; 2: 42-4. [Gnad Y.G. The combination of hyperprolactinemia and subclinical hypothyroidism. Medical advice. 2009; 2:42-44. (in Russiаn)]]
- Sayki Arslan M., Sahin M., Topaloglu O., Tutal E., Karakose M., Gungunes A. et al. Hyperprolactinaemia associated with increased thyroid volume and autoimmune thyroiditis in patients with prolactinoma. Clin. Endocrinol. (Oxford). 2013; 79(6): 882-6. https://dx.doi.org/10.1111/cen.12217.
- Brand J.M., Frohn C., Cziupka K., Brockmann C., Kirchner H., Luhm J. Prolactin triggers pro-inflammatory immune responses in peripheral immune cells. Eur. Cytokine Netw. 2004; 15(2): 99-104.
- Liu Y., Zhang Z., Jin Q., Liu Y., Kang Z., Huo Y. et al. Hyperprolactinemia is associated with a high prevalence of serum autoantibodies, high levels of inflammatory cytokines and an abnormal distribution of peripheral B-cell subsets. Endocrine. 2019; 64(3): 648-56. https://dx.doi.org/10.1007/s12020-019-01896-y.
- Dogansen S.C., Selcukbiricik O.S., Bilir B.E., Yarman S. The higher incidence of autoimmune thyroid disease in prolactinomas than in somatotrophinomas. Growth Horm. IGF Res. 2016; 29: 45-9. https://dx.doi.org/10.1016/j.ghir.2016.04.004.
- Elenkova A., Petrossians P., Zacharieva S., Beckers A. High prevalence of autoimmune thyroid diseases in patients with prolactinomas: A cross-sectional retrospective study in a single tertiary referral centre. Ann. Endocrinol. (Paris). 2016; 77(1): 37-42. https://dx.doi.org/10.1016/j.ando.2015.10.008.
- Elenkova A., Atanasova I., Kirilov G., Natchev Е., Ivanova R., Kovatcheva R. et al. Autoimmune hypothyroidism is three times more frequent in female prolactinoma patients compared to healthy women: data from a cross-sectional case-control study. Endocrine. 2017; 57(3): 486-93. https://dx.doi.org/10.1007/s12020-017-1372-8.